Riska, M., Haryati, H., Suhartono, E., & Wanahari, T. A. . (2022). Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated with Tyrosine Kinase Inhibitors. Jurnal Respirasi, 8(3), 133–139. https://doi.org/10.20473/jr.v8-I.3.2022.133-139